This site is intended for healthcare professionals only
LoginRegister
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaCDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca gets USD 107 million Pfizer verdict overturned in US cancer drug patent fight
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA grants marketing authorization for First To Know Syphilis Test for OTC use
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationIncrease sample size for immunogenicity analysis for booster dose: CDSCO Panel Tells Biological E on...
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Labs Nelarabine InjectionMSN Laboratories gets CDSCO Panel nod to conduct Bioequivalence Study of Abiraterone Tablets1000mg
DCGI Told to Act Against Unapproved Antibiotic FDCsIndia's medicine, antibiotics exports gaining share in US, Italian markets: Govt
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsANVISA-Brazil concludes inspection at Caplin Steriles Gummidipoondi facility with zero observations
Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin LymphomaBristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA grants accelerated approval to Gilead Sciences Livdelzi for Primary Biliary Cholangitis
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaAstraZeneca Imfinzi in combo with chemotherapy gets USFDA approval for treatment of resectable...
Lupin and TB Alliance Join Forces to Advance TelacebecLupin secures USFDA tentative nod for Brimonidine Tartrate Ophthalmic Solution
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma to buy over 5 percent stake in Pharmazz for up to USD 15 million
X